Please Hold Claims for Pfizer Pediatric COVID-19 Booster Vaccine Administration Services
Effective May 17, 2022, the United States Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for the Pfizer pediatric COVID-19 vaccine booster for children ages five to eleven years old. MaineCare will be updating the claims system in the coming weeks to add the following code for this service:
|
Code |
Description |
MaineCare Effective Date |
|
0074A |
Immunization Administration By Intramuscular Injection Of Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) (Coronavirus Disease [Covid-19]) Vaccine, Mrna-Lnp, Spike Protein, Preservative Free, 10 Mcg/0.2 Ml Dosage, Diluent Reconstituted, Tris-Sucrose Formulation; Booster Dose |
May 17, 2022 |
Providers of COVID-19 vaccine administration services are advised to hold claims for procedure code 0074A until the system update is complete.
We will send another message when the system update is complete. At that time providers may submit their held claims or resubmit any denied claims for code 0074A.
Please contact your Provider Relations Specialist with questions.
Check out our new MaineCare logo! Learn more about this logo on the About Us page of our website.
